Organization of Care: The “At Risk” Person in the Community
Karen S.L. Lam
The University of Hong Kong, Queen Mary Hospital, Hong Kong
Search for more papers by this authorKathryn C.B. Tan
The University of Hong Kong, Queen Mary Hospital, Hong Kong
Search for more papers by this authorKaren S.L. Lam
The University of Hong Kong, Queen Mary Hospital, Hong Kong
Search for more papers by this authorKathryn C.B. Tan
The University of Hong Kong, Queen Mary Hospital, Hong Kong
Search for more papers by this authorAbstract
With the rapidly rising prevalence of diabetes mellitus worldwide, it is imperative that strategies to prevent the development of diabetes are developed. Individuals at high risk of developing type 2 diabetes should be identified and targeted for prevention. The increased risk for diabetes stems from a combination of genetic predisposition and environmental factors. Although the genetic susceptibility to diabetes remains poorly understood, risk factors such as age, obesity, lifestyle factors including physical inactivity, a Western diet, and smoking, predispose to the development of diabetes. In women, gestational diabetes is another important risk factor for developing diabetes. Individuals with low birth weight at term and those with obstructive sleep apnea have also recently been suggested to have an increased risk.
References
- 1 American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998; 21: 296–309.
- 2 Janus ED, Wat NMS, Lam KSL, Cockram CS, Siu STS, Liu LJ, Lam TH, on behalf of the Hong Kong Cardiovascular Risk factor Steering Committee. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Diabet Med 2000; 17: 741–5.
- 3 Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829–34.
- 4 Marx J. Unraveling the causes of diabetes. Science 2002; 296: 686–9.
- 5 Pan XR, Yang WY, Li GW, Liu J, for the National Diabetes Prevention and Control Cooperative Group. Prevention of diabetes and its risk factors in China, 1994. Diabetes Care 1997; 20: 1664–9.
- 6 Janus ED, for the Cardiovascular Risk Factor Prevalence Study Group. Hong Kong Cardiovascular Risk Factor Prevalence Study (1995–1996) Monograph. Hong Kong, 1997.
- 7 Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD, for the Diabetes Epidemiological Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44: 1094–101.
- 8 Cuasay LC, Lee ES, Orlandeer PP, Steffin-Batey L, Hanis CL. Prevalence and determinants of type 2 diabetes among Filipino-Americans in the Houston, Texas metropolitan statistical area. Diabetes Care 2001; 24: 2054–8.
- 9
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care
2002; 25 (suppl 1):
S5–20.
10.2337/diacare.25.2007.S5 Google Scholar
- 10 Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–6.
- 11 Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961–9.
- 12 Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JPH, Sjostrom L. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321–6.
- 13 Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of non-insulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans—a 7-year prospective study. Obes Res 1997; 5: 16–23.
- 14 Wat NMS, Lam TH, Janus ED, Lam KSL. Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes 2001; 25: 1789–93.
- 15 Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 223: 465–71.
- 16 Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50: 1612–7.
- 17 Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001 (suppl 1): S118–21.
- 18 Li LX, Skorpen F, Egeeberg K, Jorgensen IH, Grill V. Induction of uncoupling protein 2 mRNA in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply. Endocrinology 2002; 143: 1371–7.
- 19 Zhang Cy, Baffy G, Perret P, Krauus S, Peroni O, Gujic D, Hagen T, Vidal-puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001; 105: 705–7.
- 20 Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001; 50: 810–6.
- 21 Hu FB, Manson JE, Stampfer MJ, Colditz GC, Liu S, Solomon CG, Willett WC. Diet, lifestyle and the risk of type 2 diabetes mellitus in women. N Engl J Med 1997; 337: 1491–9.
- 22 Mayer-Davis E, D'Agnostino R, Karter AJ, Haffner SM, Rewers MJ, Sadd M, Bergman RN. Intensity of amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 1998; 279: 669–74.
- 23 Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ. March 4 1995; 310: 560–4.
- 24 Hu FB, Leithzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB. Physical activity and television watching in relation to risk for type 2 diabetes in men. Arch Intern Med 2001; 161: 1542–8.
- 25 van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002; 136: 201–9.
- 26 Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277: 472–7.
- 27 van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fats and meat intake in relation to risk of type 2 diabetes in man. Diabetes Care 2002; 25: 417–24.
- 28 Rimm EB, Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, Speizer FE. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993; 83: 211–41.
- 29 Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willet WC. Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. BMJ 1995; 310: 555–9.
- 30 Manson JA, Ajani UA, Liu S, Nathan DM, Hennekens CH. A prospective study of cigarette smoking and the incidence of diabetes mellitus among U.S. male physicians. Am J Med 2000; 109: 538–42.
- 31 Wannamethee SG, Shaper AG, Perry IJ, for the British Regional Heart Study Group. Smoking as modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 2001; 24: 1590–5.
- 32 Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997; 27: 450–6.
- 33 Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interlukin-6 and risk of developing type 2 diabetes. JAMA 2001; 286: 327–34.
- 34 Festa A, D'Agostino R Jr, Tracy R, Haffner SM. Elevated levels of acute phase proteins and development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 1131–7.
- 35 Wannanmethee SG, Shaper AG, Perry IJ, Alberti KG. Alcohol consumption and the incidence of type 2 diabetes. J Epidemiol Community Health 2002; 56: 542–8.
- 36 Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 2002; 155: 387–93.
- 37 Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnoea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670–6.
- 38 Funjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677–82.
- 39Buchanan TA. Pancreatic beta-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 989–93.
- 40 Maresh M. Diabetes in pregnancy. Curr Opin Obstet Gynecol 2001; 13: 103–7.
- 41 Kjos SL, Peters RK, Xiang A, Henry OA, Montoro MN, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 1995; 44: 586–91.
- 42 Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care 1995; 18: 611–7.
- 43 Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibship. Diabetes 2000; 49: 2208–11.
- 44 Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, Speizer FE, Stampfer MJ. Birth weight and adult hypertension and obesity in women. Circulation 1996; 94: 1310–5.
- 45 Curhan GC, Willett WC, Rimm B, Spiegelman D, Ascheiro AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in U.S. men. Circulation 1996; 94: 3246–50.
- 46 Frankel S, Elowood P, Sweetnam P, Yarnell J, Davey Smith G. Birth weight, body mass index in middle age, and incident coronary heart disease. Lancet 1996; 348: 1478–80.
- 47 Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000; 71 (suppl 1): 1344S–52.
- 48 Phenekos C. Influence of fetal body weight on metabolic complications in adult life: review of the evidence. J Paediatr Endocrinol Metab 2001; 14 (suppl 5): 1361–3.
- 49 Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Takali S, Barbaretta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescence with marked obesity. N Engl Med 2002; 346: 802–10.
- 50 Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng HM, Zhang H, Baenett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537–44.
- 51 Tuomilehto J, Eriksson JG, Hamalainen H, Hanne-Paarikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group. Prevention of type 2 dia-betes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 343–50.
- 52 Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention of metformin. N Engl Med 2002; 346: 393–403.